Drugs / Qurse Mafasil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02612974 Background | Jan 2010 → Mar 2012 | osteoarthritis, knee | Hamdard University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qurse Mafasil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02612974 ↗ |
| Route | Oral | “Qurse Mafasil tablet orally two tablets two times daily for 8 weeks” NCT02612974 ↗ |